Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming ...

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and ...

Indiana Attorney General Todd Rokita is suing two pharmaceutical companies over alleged anticompetitive acts regarding a life ...

The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...

The state also says the companies paid doctors to say a 2-pak of EpiPen is medically necessary, so that the companies could stop selling individual EpiPens. EpiPen is the name brand for an epinephrine ...

Epinephrine 0.15mg (1:2000); prefilled auto-injector; contains sulfites. Epinephrine acts on both alpha- and beta-adrenergic receptors. Through its action on alpha-adrenergic receptors ...

An EpiPen can be a lifesaving measure that allows ... but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not ...

The lawsuit alleges the price increases EpiPen, used to treat severe allergic reactions, prevented other similar medications ...

The EpiPen totally dominates the market. Either people don't know about the cheaper alternatives, or they do - but don't want to buy them. Business Insider looked at the number of prescriptions ...

“For people with severe allergies, immediate access to an EpiPen device can mean the difference ... requiring those in need to purchase the medication repeatedly.